| Acute rheumatic fever and rheumatic heart disease JR Carapetis, A Beaton, MW Cunningham, L Guilherme, G Karthikeyan, ... Nature reviews Disease primers 2 (1), 1-24, 2016 | 666 | 2016 |
| Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease B Remenyi, J Carapetis, R Wyber, K Taubert, BM Mayosi Nature Reviews Cardiology 10 (5), 284-292, 2013 | 343 | 2013 |
| Big data in global health: improving health in low-and middle-income countries R Wyber, S Vaillancourt, W Perry, P Mannava, T Folaranmi, LA Celi Bulletin of the World Health Organization 93, 203-208, 2015 | 255 | 2015 |
| The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease AP Ralph, S Noonan, V Wade, BJ Currie Medical Journal of Australia 214 (5), 220-227, 2021 | 248* | 2021 |
| Rheumatic Heart Disease Worldwide: JACC Scientific Expert Panel DA Watkins, AZ Beaton, JR Carapetis, G Karthikeyan, BM Mayosi, ... Journal of the American College of Cardiology 72 (12), 1397-1416, 2018 | 225 | 2018 |
| Global disease burden of group A Streptococcus AS Sanyahumbi, S Colquhoun, R Wyber, JR Carapetis Streptococcus pyogenes: basic biology to clinical manifestations [Internet], 2016 | 198* | 2016 |
| Contemporary incidence and prevalence of rheumatic fever and rheumatic heart disease in Australia using linked data: the case for policy change JM Katzenellenbogen, D Bond‐Smith, RJ Seth, K Dempsey, J Cannon, ... Journal of the American Heart Association 9 (19), e016851, 2020 | 109 | 2020 |
| Benzathine penicillin G for the management of RHD: concerns about quality and access, and opportunities for intervention and improvement R Wyber, K Taubert, S Marko, EL Kaplan Global heart 8 (3), 227-234, 2013 | 77 | 2013 |
| Rheumatic heart disease: infectious disease origin, chronic care approach JM Katzenellenbogen, AP Ralph, R Wyber, JR Carapetis BMC health services research 17, 1-16, 2017 | 65 | 2017 |
| The WHF roadmap for reducing CV morbidity and mortality through prevention and control of RHD B Palafox, AO Mocumbi, RK Kumar, SKM Ali, E Kennedy, A Haileamlak, ... Global heart 12 (1), 47-62, 2017 | 59 | 2017 |
| Ending rheumatic heart disease in Australia: the evidence for a new approach R Wyber, K Noonan, C Halkon, S Enkel, J Cannon, E Haynes, AG Mitchell, ... Medical Journal of Australia 213, S3-S31, 2020 | 54 | 2020 |
| The case for global investment in rheumatic heart-disease control R Wyber, L Zühlke, J Carapetis Bulletin of the World Health Organization 92, 768-770, 2014 | 44 | 2014 |
| Voices behind the statistics: a systematic literature review of the lived experience of rheumatic heart disease E Haynes, A Mitchell, S Enkel, R Wyber, D Bessarab International Journal of Environmental Research and Public Health 17 (4), 1347, 2020 | 42 | 2020 |
| Tools for implementing RHD control programmes (TIPS) handbook R Wyber, A Grainger Gasser, D Thompson, D Kennedy, T Johnson, ... Perth, Australia: World Heart Federation and RhEACH, 2014 | 42 | 2014 |
| The American Heart Association’s call to action for reducing the global burden of rheumatic heart disease: a policy statement from the American Heart Association A Beaton, FB Kamalembo, J Dale, JH Kado, G Karthikeyan, DS Kazi, ... Circulation 142 (20), e358-e368, 2020 | 40 | 2020 |
| The End Rheumatic Heart Disease in Australia Study of Epidemiology (ERASE) Project: data sources, case ascertainment and cohort profile JM Katzenellenbogen, D Bond-Smith, RJ Seth, K Dempsey, J Cannon, ... Clinical Epidemiology, 997-1010, 2019 | 34 | 2019 |
| Prevention of rheumatic fever and heart disease: Nepalese experience PR Regmi, R Wyber Global heart 8 (3), 247-252, 2013 | 32 | 2013 |
| Rheumatic heart disease in Indigenous young peoples R Wyber, V Wade, A Anderson, Y Schreiber, R Saginur, A Brown, ... The Lancet Child & Adolescent Health 5 (6), 437-446, 2021 | 29 | 2021 |
| The RHD Endgame Strategy; the blueprint to eliminate rheumatic heart disease in Australia by 2031 R Wyber, K Noonan, C Halkon, S Enkel, J Carapetis European Journal of Public Health 30 (Supplement_5), ckaa165. 059, 2020 | 29 | 2020 |
| Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever R Wyber, BJ Boyd, S Colquhoun, BJ Currie, M Engel, J Kado, ... Drug Delivery and Translational Research 6, 572-578, 2016 | 29 | 2016 |
